Late Relapse of Diabetes After Bariatric Surgery: Not Rare, but Not a Failure
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To characterize the status of cardiometabolic risk factors after late relapse of type 2 diabetes mellitus (T2DM) and to identify factors predicting relapse after initial diabetes remission following bariatric surgery to construct prediction models for clinical practice. RESEARCH DESIGN AND METHODS: Outcomes of 736 patients with T2DM who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at an academic center (2004–2012) and had ≥5 years’ glycemic follow-up were assessed. Of 736 patients, 425 (58%) experienced diabetes remission (HbA1c <6.5% [48 mmol/mol] with patients off medications) in the 1st year after surgery. These 425 patients were followed for a median of 8 years (range 5–14) to characterize late relapse of diabetes. RESULTS: In 136 (32%) patients who experienced late relapse, a statistically significant improvement in glycemic control, number of diabetes medications including insulin use, blood pressure, and lipid profile was still observed at long-term. Independent baseline predictors of late relapse were preoperative number of diabetes medications, duration of T2DM before surgery, and SG versus RYGB. Furthermore, patients who relapsed lost less weight during the 1st year after surgery and regained more weight afterward. Prediction models were constructed and externally validated. CONCLUSIONS: While late relapse of T2DM is a real phenomenon (one-third of our cohort), it should not be considered a failure, as the trajectory of the disease and its related cardiometabolic risk factors is changed favorably after bariatric surgery. Earlier surgical intervention, RYGB (compared with SG) and more weight loss (less late weight regain) are associated with less diabetes relapse in the long-term.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, patients may only experience partial remission of comorbidities; e.g., a large number of patients who experience complete T2D remission in the early period after surgery suffer a relapse on long-term follow-up [4].”
Citations
Cites
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934 · cited 1×
“not at this target 5 years after surgery (9).”
BackgroundSelf-citationSjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundMingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundIFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3450-2 · Cited by 1,032 · cited 1×
“95% of the primary bariatric procedures worldwide in patients with T2DM (33,34) means that the findings of this study will be relevant to the practice of most of the bariatric surgeons globally.”
BackgroundHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003 · cited 4×
“© 2020 by the American Diabetes Association.”
MethodInfluentialSalminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946 · cited 1×
“1) Hospital Cĺınic de Barcelona, 2) patients with T2DM who were enrolled in the Sleeve vs Bypass (SLEEVEPASS) randomized clinical trial (16) from Finland, and 3) patients from Geisinger Clinic in Danville, PA.”
MethodSelf-citationStandardized outcomes reporting in metabolic and bariatric surgery
Brethauer, S. A., Kim, J., el Chaar, M., Papasavas, P., Eisenberg, D., Rogers, A., Ballem, N., Kligman, M., & Kothari, S. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.003 · Cited by 944
Self-citationBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552
Self-citationAminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E. (2019) · JAMA · doi:10.1001/jama.2019.14231 · Cited by 505
Self-citation
Cited by
Items 101–128 of 128
Bariatric and Metabolic Surgery in Japan - Past, Present and Future -
Tatsuno, I. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.109
Kindel, T. L. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.03.005
Tatsuno, I. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.449
Adyuvancia farmacológica poscirugía metabólica
Ackermann, M. A. (2022) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i3sup.572
Tatsuno, I. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.1931
Diabetes Mellitus 2 de nueva aparición después de la cirugía bariátrica
Yolanda, O. G. S., & Barrozo, J. M. C. (2023) · Revista Medica · doi:10.58296/rm.v28i1.65
Management of type 2 diabetes after metabolic bariatric surgery
Tham, K. W., & Lee, P. C. (2023) · Mini-invasive Surgery · doi:10.20517/2574-1225.2023.80 · Cited by 1
de Lima, A. P. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-07052024-151215
Althumiri, N. A., BinDhim, N. F., Al-Rayes, S., & Alumran, A. K. (2024) · Research Square · doi:10.21203/rs.3.rs-4658634/v1
Current Approach of Diabetes Mellitus in Obese Patients
Karaburgu, S. (2023) · doi:10.69860/nobel.9786053359111.8
Tempany, J., Ali, A., & Collier, A. (2024) · Cureus · doi:10.7759/cureus.70921
L’arthrose chez le patient obèse : impact de la chirurgie bariatrique sur son évolution
Eymard, F., & Aron‐Wisnewsky, J. (2024) · Revue du Rhumatisme · doi:10.1016/j.rhum.2024.12.005
Il diabete dopo chirurgia bariatrica: non un vero fallimento
Stefano, C. D., Vinciguerra, F., Baratta, R., & Frittitta, L. (2025) · il Diabete · doi:10.30682/ildia2404d
Elkassem, S. (2025) · European surgery. Supplement/European surgery · doi:10.1007/s10353-025-00858-1
“…however, other studies suggest a possible legacy effect and improved disease trajectory with improved glycemic control in patients with advanced disease undergoing GB compared to SG [9, 30, 31], suggesting the importance of achieving enhanced glycemic outcomes in patients with advanced disease.”
The Concept of Sleeve Gastrectomy for Two Stages
Deffain, A., & Denis, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-77690-8_89-1
Voznesenskaya, А. А., Pershina-Miliutina, A. P., Вячеславович, А. А., Rozhevskaya, E. E., Томилова, А. О., Shestakova, E. A., Sineokaya, M. S., Ershova, E. V., Stafeev, I., Yashkov, Y. I., et al. (2025) · Diabetes Mellitus · doi:10.14341/dm13348
“Данное обстоятельство также требует проведения дальнейших исследований, поскольку во многих работах сообщалось о заведомо большей метаболической эффективности БПШ в сравнении с ГШ [14], а также шунтирующих операций в сравнении с продольной резекцией желудка [15].”
Glycemic effects after bariatric surgery
Jans, A. (2025) · Örebro University Library (Örebro University)
Schmidt, V., & Kim, S. (2024) · eScholarship (California Digital Library)
Microbiote intestinal et vitamines B dans l’obésité sévère : le cas de la biotine
Voland, L. (2022) · theses.fr (ABES) · doi:10.70675/3d6ab2f6z3844z4eccz9cbazdd1ace927949
Khan, M. B., Amina, Shah, M. N., & Ahmad, S. (2026) · Cureus · doi:10.7759/cureus.111058
“Aminian et al. observed that, although there is a risk of late-relapsing diabetes following bariatric surgery, that is not a failure of treatment [19].”
Metabolic Surgery: Outcomes and Choice
Aminian, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-24278-5_10
Self-citationCiesielska, J., Bartosik, K., Niewęgłowski, M., Marczuk, S., Nazaruk, I., & Wyroślak-Najs, J. (2026) · Clinical Diabetology · doi:10.5603/cd.112355
Barboza, B. P., Ferrara, P., Ye, L., Losa, L., Perseghin, G., Cesana, G. C., Berta, P., & Mantovani, L. G. (2026) · Obesity Reviews · doi:10.1111/obr.70211
Follow up after metabolic bariatric surgery
Goldenshluger, A. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.08.008
Berrocal, C., Echeverri, D. A., Quintana, J. H., Bocanegra, J. L. P., Carrascal, V. A. C., Lafont, E. M. P., Quiñones, M. D. P., Pacheco, G. D., Buitrago, J. P. M., Arellano-Cabeza, A. A., et al. (2026) · Cureus · doi:10.7759/cureus.118471
Nie, Y., Lv, J., Liu, B., & Meng, H. (2026) · Obesity Surgery · doi:10.1007/s11695-026-09006-4
Sun, J., Anyalebechi, J., Najafi, B., Rosenthal, R. J., & Livingston, E. H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71472
Metadata
- Authors
- Aminian, A., Vidal, J., Salminen, P., Still, C. D., Nor Hanipah, Z., Sharma, G., Tu, C., Wood, G. C., Ibarzabal, A., Jimenez, A., Brethauer, S. A., Schauer, P. R., & Mahawar, K.
- Affiliations
- Cleveland Clinic (US)
- Obesity Unit, Hospital Clínic de Barcelona, Barcelona, Spain
- University of Turku (FI)
- Geisinger Medical Center (US)
- Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, OH
- Pennington Biomedical Research Center (US)
- Sunderland Royal Hospital (GB)
- Corresponding author
- Aminian, Ali
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-01-23
- Volume
- 43
- Issue
- 3
- Pages
- 534-540
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3001053202
- Cited by
- 122
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 21 · 2021: 28 · 2020: 14
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- green
- psasir.upm.edu.my
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, bariatric surgery, late recurrence, diabetes remission, Roux-en-Y gastric bypass, sleeve gastrectomy, weight regain, cardiometabolic risk factors, predictors of relapse, prediction model, insulin use, long-term outcomes
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gastrectomy, Humans, Male, Middle Aged, Prognosis, Recurrence, Retrospective Studies, Time Factors, Gastric Bypass, Weight Loss, Incidence, Treatment Failure, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.